263 related articles for article (PubMed ID: 27521316)
1. Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.
Haverkos BM; Gru AA; Geyer SM; Bingman AK; Hemminger JA; Mishra A; Wong HK; Pancholi P; Freud AG; Caligiuri MA; Baiocchi RA; Porcu P
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl(Suppl):S181-S190.e4. PubMed ID: 27521316
[TBL] [Abstract][Full Text] [Related]
2. Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.
Haverkos BM; Huang Y; Gru A; Pancholi P; Freud AG; Mishra A; Ruppert AS; Baiocchi RA; Porcu P
Int J Cancer; 2017 Apr; 140(8):1899-1906. PubMed ID: 27943278
[TBL] [Abstract][Full Text] [Related]
3. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
[TBL] [Abstract][Full Text] [Related]
4. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
5. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Kanakry JA; Li H; Gellert LL; Lemas MV; Hsieh WS; Hong F; Tan KL; Gascoyne RD; Gordon LI; Fisher RI; Bartlett NL; Stiff P; Cheson BD; Advani R; Miller TP; Kahl BS; Horning SJ; Ambinder RF
Blood; 2013 May; 121(18):3547-53. PubMed ID: 23386127
[TBL] [Abstract][Full Text] [Related]
6. Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.
Alfieri S; Iacovelli NA; Marceglia S; Lasorsa I; Resteghini C; Taverna F; Mazzocchi A; Orlandi E; Guzzo M; Bianchi R; Fanti D; Pala L; Racca S; Dvir R; Quattrone P; Gloghini A; Volpi CC; Granata R; Bergamini C; Locati L; Licitra L; Bossi P
Oncotarget; 2017 Jul; 8(29):47780-47789. PubMed ID: 28562354
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients.
Okamoto A; Yanada M; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
Hematol Oncol; 2017 Mar; 35(1):87-93. PubMed ID: 26177728
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
Okamoto A; Yanada M; Miura H; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
Cancer Sci; 2015 Nov; 106(11):1576-81. PubMed ID: 26353084
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood.
Novelli M; Merlino C; Ponti R; Bergallo M; Quaglino P; Cambieri I; Comessatti A; Sidoti F; Costa C; Corino D; Cavallo R; Ponzi AN; Fierro MT; Bernengo MG
J Invest Dermatol; 2009 Jun; 129(6):1556-61. PubMed ID: 19131945
[TBL] [Abstract][Full Text] [Related]
10. [Epstein-Barr virus research by in situ hybridization in 65 cutaneous T cell epidermotropic lymphomas].
Jumbou O; Huet S; Bureau B; Litoux P; Dréno B
Ann Dermatol Venereol; 1998 Feb; 125(2):90-3. PubMed ID: 9747220
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma.
Liang JH; Lu TX; Tian T; Wang L; Fan L; Xu J; Zhang R; Gong QX; Zhang ZH; Li JY; Xu W
Clin Microbiol Infect; 2015 Jun; 21(6):596-602. PubMed ID: 25743579
[TBL] [Abstract][Full Text] [Related]
12. Primary Cutaneous Extranodal Natural Killer/T-Cell Lymphoma Misdiagnosed as Peripheral T-Cell Lymphoma: The Importance of Consultation/Referral and Inclusion of EBV In Situ Hybridization for Diagnosis.
Win KT; Liau JY; Chen BJ; Takata K; Chen CY; Li CC; Hsiao CH; Chuang SS
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):105-11. PubMed ID: 25710587
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
Su IJ; Tsai TF; Cheng AL; Chen CC
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539
[TBL] [Abstract][Full Text] [Related]
14. Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides.
Shimakage M; Sasagawa T; Kawahara K; Yutsudo M; Kusuoka H; Kozuka T
Int J Cancer; 2001 Apr; 92(2):226-31. PubMed ID: 11291050
[TBL] [Abstract][Full Text] [Related]
15. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796
[TBL] [Abstract][Full Text] [Related]
16. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic significance of plasma Epstein-Barr virus DNA in patients with diffuse large B cell lymphoma].
An N; Xie YP; Xu Y; Shi PF; Qian SX
Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):839-841. PubMed ID: 29136714
[TBL] [Abstract][Full Text] [Related]
18. Detection of EBER nuclear RNA in T-cell lymphomas involving the skin--an in situ hybridization study.
Park CK; Ko YH
Br J Dermatol; 1996 Mar; 134(3):488-93. PubMed ID: 8731674
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.
Huang WT; Chang KC; Huang GC; Hsiao JR; Chen HH; Chuang SS; Chen TY; Su WC; Tsao CJ
Haematologica; 2005 Aug; 90(8):1063-9. PubMed ID: 16079105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
